European VC Funds

Hippocrates VC is a physician-backed venture capital firm specializing in digital health startups. With a focus on impact-driven investments, they aim to transform healthcare delivery through innovative technologies. Notable portfolio companies include Fruit Street, which provides diabetes prevention via telehealth, and Avive AED, developing life-saving tools for sudden cardiac arrest. Smiley Scope, another investment, uses VR to improve patient outcomes. Their geographic focus is primarily the U.S., and they target startups that can scale globally. Hippocrates seeks early-stage ventures, often leading rounds with an average check size of $500k to $2M. They prefer companies at the intersection of healthcare and technology, especially those offering digital therapeutics or telemedicine solutions. The fund is led by Laurence Girard, a healthcare entrepreneur who previously raised over $40M for his ventures. Under his leadership, Hippocrates maintains a strong network of physician investors, creating a unique ecosystem for healthcare innovation. To approach the fund, startups are encouraged to demonstrate clear clinical impacts and a solid path to commercialization, especially within regulated healthcare markets.

Hive Data, also known as The Hive, is a Palo Alto-based venture fund and co-creation studio dedicated to launching AI-driven startups with an emphasis on data science, blockchain, and other advanced technologies. As both investor and hands-on collaborator, Hive Data engages early-stage startups through a high-touch model, providing pre-seed and seed capital (typically between $1.5 million to $3 million) alongside extensive support in product development, go-to-market strategies, and securing additional funding. The Hive focuses on enterprise applications across sectors like digital health, fintech, insurance, and industrials, targeting innovative solutions in areas such as machine learning, computer vision, and ambient intelligence. They also foster an innovation ecosystem through The Hive Think Tank, a prominent thought-leadership community that connects AI and data professionals in the Bay Area and beyond. This platform brings together corporations, startups, and investors, offering events, resources, and networking opportunities, and includes partners like IBM, Microsoft, and Cloudera. The Hive operates globally with separate funds in regions including Brazil, India, and Southeast Asia, expanding their collaborative model of company-building across multiple continents. Key team members, like T.M. Ravi and Sumant Mandal, bring deep expertise from Silicon Valley and beyond, leveraging backgrounds in tech leadership and venture capital to guide their portfolio companies through early growth stages.

Hiventures, a Hungarian state-owned venture capital fund, is renowned for its extensive portfolio and dynamic investment strategy. With a focus on supporting startups from pre-seed to growth stages, Hiventures has made over 770 investments across various sectors, including software services, cloud computing, and cybersecurity. Notable investments include Access4you, iBar Experience, and Surviot Monitoring, showcasing their commitment to innovation in diverse industries. Geographically, Hiventures primarily invests within Hungary, emphasizing the growth of the local entrepreneurial ecosystem. Their strategy involves flexible investment conditions and a quick adaptation to the needs of startups, making them a preferred partner for early-stage ventures. Hiventures typically invests around $983,000 per round, actively leading many of these investments. They maintain a high engagement level, with an average of 30.96 rounds per year, peaking in 2021. The fund's team, including key figures like CEO Eszter Jandrasics and Senior Investment Manager Ádám Horváth, brings deep expertise in venture capital and business development. For startups looking to approach Hiventures, it's beneficial to highlight innovative solutions and scalability. They prefer well-prepared pitches that align with their focus on fostering technological advancements and economic growth in Hungary.

Hong Kong Science and Technology Parks Corporation (HKSTP) is the leading innovation and technology (I&T) ecosystem in Hong Kong. Established in 2001, HKSTP fosters tech startups and industry growth, focusing on sectors like healthtech, AI and robotics, fintech, and smart city innovations. The corporation manages a network that includes the Hong Kong Science Park, InnoCentre, and InnoParks, supporting over 1,700 companies and 14,000 R&D professionals. HKSTP offers full-cycle support to startups, from incubation and prototyping to funding and commercialization. They manage the HKSTP Venture Fund, a HK$1 billion asset fund, to support high-growth tech ventures, and have groomed multiple unicorns within their ecosystem. With strong connections to the Greater Bay Area, HKSTP also helps companies expand into mainland China. Their resources include world-class R&D labs, co-working spaces, advanced manufacturing centers, and a broad investor network. HKSTP’s mission is to drive collaboration, accelerate innovation, and cultivate talent for Hong Kong and the broader region, positioning the city as a leading global innovation hub.

HOF Capital is a global venture capital firm headquartered in New York, focused on investing in transformative technology companies from idea to IPO. With support from over 70 influential family offices, global corporations, and institutions, HOF provides startups with more than just capital—they offer strategic partnerships that open doors to new markets, customer bases, and operational growth. Their portfolio features industry-leading companies such as Alibaba, Epic Games, UiPath, and ASAPP. HOF Capital specializes in sectors like fintech, deep tech, healthcare, and logistics, making investments from pre-seed to late-stage rounds. The firm’s approach emphasizes long-term value creation, guiding entrepreneurs through various growth stages with business development, sales, and fundraising support. With offices in New York, London, and San Francisco, and a team of investors spread across key global regions, HOF operates as a bridge between startups and large-scale enterprises. Co-founded by Hisham Elhaddad, Onsi Sawiris, and Fady Yacoub, HOF leverages its vast network of partners, including industry giants like Visa, Nvidia, and Daimler, to provide startups with critical resources and strategic advice. Their multi-stage investment strategy, combined with deep industry knowledge and a vast network, helps startups scale quickly while navigating complex challenges in highly competitive environments.

HV Capital, formerly known as HV Holtzbrinck Ventures, is a leading venture capital firm based in Munich and Berlin, Germany. Established in 2000, HV Capital has a robust track record of investing in early-stage and growth-stage companies across Europe, particularly in the tech sector. The firm manages over €2.8 billion in assets and has backed around 225 companies to date. The firm recently closed its largest fund yet, HV Capital Fund IX, at €710 million. This fund is split into two vehicles: Fund IX Venture, targeting early-stage investments, and Fund IX Growth, focusing on later-stage companies from Seed to Series D and beyond​. HV Capital's investment strategy includes initial ticket sizes ranging from €0.5 million to €60 million, with the capability to provide follow-on investments up to €100 million per company​. HV Capital's portfolio includes several successful companies such as Flixbus, HelloFresh, Delivery Hero, and SumUp. The firm also emphasizes sustainability, with specific commitments to advancing ESG (Environmental, Social, and Governance) principles within its investments​. The team at HV Capital consists of 35 members, including 14 partners, who leverage their extensive experience to support and grow their portfolio companies. The firm operates with a long-term perspective, often supporting companies for over a decade​.

Hovione Capital, now known as Bionova Capital, is a healthcare-focused venture capital firm based in Lisbon, Portugal. The firm was established in 2015 by the shareholders of Hovione, a leading pharmaceutical company. In February 2021, Hovione Capital rebranded to Bionova Capital to reflect its expanded focus on disruptive life science companies across Europe. Bionova Capital invests in early-stage companies specializing in breakthrough therapeutics, medtech, and digital health. The firm has built a strong reputation for being an active, value-adding investor, supporting startups with capital, strategic guidance, and access to a broad network of industry experts. The firm’s portfolio includes successful investments like CellmAbs, a notable biotech deal in Europe. Recently, Bionova Capital has shifted its new investment activities to Biovance Capital Partners, an independent venture capital company established by the Bionova team. This new fund, Biovance Capital Fund I, focuses on early-stage biotech companies and has secured up to €60 million for its investment activities.

Hoxton Ventures is a London-based early-stage venture capital firm known for backing some of Europe’s most successful startups, including Deliveroo, Babylon Health, and Darktrace. Founded in 2013, Hoxton focuses on investing in disruptive technology companies with the potential to become global leaders in their sectors. The firm primarily targets startups at the pre-seed and seed stages, helping them scale with both financial support and strategic guidance. Hoxton Ventures has a strong track record of identifying innovative companies across diverse industries such as fintech, healthcare, AI, and enterprise software. Their portfolio includes notable investments that have either gone public or reached unicorn status. The firm operates as a partner-only team, ensuring that founders receive direct attention and mentorship from experienced investors who have backgrounds in building and scaling companies themselves. With a proactive approach, Hoxton leverages deep industry expertise and a global network to support the growth of its portfolio companies. The firm typically invests above €3 million and provides operational support to help startups navigate their early stages, positioning them for long-term success in the competitive European startup ecosystem.

HP Tech Ventures, established in 2016, is the venture capital arm of HP Inc., designed to fuel innovation by strategically investing in early-stage startups that are poised to disrupt the tech landscape. The firm’s investment focus spans a variety of high-impact areas, including generative AI, edge computing, hybrid work solutions, 3D printing, and sustainability. These sectors align with HP's broader vision of shaping the future through transformative technologies. HP Tech Ventures not only provides capital but also offers its portfolio companies access to HP’s global resources, including one of the world’s largest channel and distribution networks, deep technological expertise, and a vast manufacturing and supply chain infrastructure. This support helps startups scale rapidly and achieve significant market impact. The firm’s portfolio is diverse, including companies like Mojo Vision, a pioneer in micro-LED technology, and Owl Labs, which focuses on solutions for hybrid work environments. HP Tech Ventures has also seen successful exits, such as the acquisition of Mobalytics, a gaming analytics platform, by Tencent, and Voxel8, a 3D printing startup, by DSM. These exits demonstrate HP Tech Ventures' ability to identify and nurture companies that deliver substantial returns and technological advancements. The team at HP Tech Ventures, led by Andrew Bolwell, Angelo Del Priore, and others, brings extensive experience in both the technology and venture capital sectors. They actively engage with portfolio companies, offering strategic guidance and leveraging HP’s vast network to accelerate growth. With investments primarily in the U.S. and Israel, HP Tech Ventures continues to be a key player in driving innovation across the tech industry.

Hubraum, Deutsche Telekom's tech incubator, is dedicated to fostering innovation in 5G, AI, IoT, and other advanced technologies by bridging the gap between early-stage startups and the extensive resources of Deutsche Telekom. Established in 2012, Hubraum operates from Berlin, Krakow, and Tel Aviv, providing startups with access to mentorship, investment, and Deutsche Telekom's extensive networks, clients, and technology. Hubraum has made over 50 investments, focusing primarily on pre-seed, seed, and Series A stages. Their portfolio includes notable companies like Blinkist, Relayr, and TEXEL, with recent investments in Salvador Technologies and Phelas. These investments highlight Hubraum’s commitment to supporting cutting-edge innovations in various tech sectors including IoT, big data, and AI. The incubator not only offers financial backing but also provides free coworking space and a robust support system to help startups scale their businesses. This comprehensive approach ensures that startups have the necessary resources and guidance to succeed in a competitive tech landscape. Through these initiatives, Hubraum plays a crucial role in driving technological advancement and creating new business opportunities​.

Hummingbird VC, founded in 2010 and based in Antwerp, Belgium, is an early-stage venture capital firm that invests globally, backing founders with groundbreaking ideas. The firm has a strong portfolio with notable investments in companies like Deliveroo, Kraken, and Peak Games. Hummingbird VC focuses on a wide array of industries including fintech, biotech, deep tech, healthcare, and marketplaces, with investments across North America, EMEA, and APAC regions. Hummingbird's investment strategy centers on partnering early with outlier founders and providing unwavering support through the company's lifecycle. They are known for their high conviction and willingness to make substantial investments, often leading funding rounds with check sizes ranging from $500K to over $50M. They prefer a low-friction partnership approach, allowing entrepreneurs to dictate the level of involvement and support needed. Key figures in the team include Barend Van den Brande, the founder, who is based in Belgium, and other partners spread across their international offices. Hummingbird is noted for its patient capital and long-term support, especially during challenging times for startups. They emphasize radical candor and dedication to the founders they back, aiming to foster transformative growth and industry disruption.

Hydra Ventures is the corporate venture arm of Adidas, based in Amsterdam, Netherlands. Established in 2011, Hydra Ventures focuses on investing in companies that develop new consumer brands and trends, particularly in the areas of apparel, footwear, and sports-related technologies. Backed by the full support of Adidas, Hydra Ventures seeks to identify and nurture innovative companies that align with the broader strategic goals of Adidas, particularly in areas related to lifestyle and athletic performance. The firm operates with a focus on fostering new consumer experiences and tapping into emerging markets that have the potential to influence the future of sports and fashion. By investing in early-stage companies, Hydra Ventures aims to drive growth in the sports and lifestyle sectors, helping startups scale and integrate with Adidas’ broader ecosystem. Hydra Ventures plays a strategic role in helping Adidas stay at the forefront of innovation in the highly competitive sportswear industry by enabling the development of cutting-edge technologies and new business models. Through its investments, Hydra Ventures not only supports the growth of its portfolio companies but also strengthens Adidas’ market position by leveraging the innovations and consumer insights generated by these ventures.

iBionext is a Paris-based Venture Studio focused on creating, developing, and financing innovative startups in the healthcare and deep tech sectors. Established in 2016, iBionext operates with a unique "Spot, Boost, and Grow" strategy. This approach identifies disruptive technologies in healthcare, nurtures them into high-potential startups, and supports their growth into industry leaders. The firm specializes in deep tech and health tech innovations, including biotechnology, medical devices, digital health, and bio-inspired technologies. iBionext’s ecosystem, known as "Le Passage de l’Innovation," provides comprehensive support through a team of experts in science, law, finance, and entrepreneurship. This ecosystem enables startups to scale efficiently while minimizing operational risks. Notable companies within the iBionext portfolio include Prophesee, known for its neuromorphic vision technology, and GrAI Matter Labs, which focuses on AI-driven computing solutions. By the end of 2023, iBionext's first fund had helped raise over €200 million for its portfolio companies, creating more than 200 specialized jobs.

Icebreaker.vc, established in 2016 and based in Helsinki, focuses on early-stage investments, particularly in Finland, Sweden, and Estonia. They target pre-seed and seed-stage companies with investments ranging from €150,000 to €800,000. Icebreaker.vc's portfolio includes notable companies such as Valpas, Lumoa, Workfellow, and Oterlu. Icebreaker.vc supports teams with deep domain expertise and a vision for global impact, spanning various sectors like fintech, healthcare, consumer goods, and energy. They emphasize strong, complementary founding teams and provide extensive support through their community of over 1,000 experienced professionals. The firm has raised significant funds to continue backing innovative startups, including a recent €120 million fund to further invest in and support their portfolio companies from the earliest stages. Key team members include Lasse Lehtinen, Aleksi Partanen, and Riku Seppälä, all of whom bring extensive experience in founding and scaling tech companies. Their approach combines capital with strategic operational support to help startups navigate growth challenges and achieve market success.

ICONIQ Capital, a multifaceted investment management firm headquartered in San Francisco, manages over $80 billion in assets. The firm is known for serving influential families and organizations, particularly those in technology, high finance, and entertainment sectors. ICONIQ has a robust portfolio featuring investments in prominent tech companies. Notable portfolio companies include Airbnb, Alibaba, Facebook, Snowflake, and Uber. They also have significant stakes in innovative firms like OpenAI, HashiCorp, and Miro, showcasing their focus on transformative technologies and scalable business models. Their investment strategy involves partnering with inspired entrepreneurs to drive industry transformation. ICONIQ Capital provides not only financial support but also strategic guidance, leveraging their extensive network to foster growth and innovation. The firm operates globally with offices in New York, London, and Hong Kong, offering a comprehensive range of services including private equity, venture capital, real estate, and philanthropic advisory. ICONIQ's team comprises experienced professionals like Divesh Makan, one of the founders, who bring deep expertise and a hands-on approach to managing investments and advising clients.

Icos Capital is a Dutch venture capital firm specializing in ClimateTech investments, focusing on sectors such as food systems, decarbonization, sustainable chemicals, and materials. Since its founding in 2005, Icos Capital has been committed to supporting early-growth stage companies that drive sustainability and industrial decarbonization. The firm is known for its Collaborative Venturing Platform (CVP), which connects startups with leading corporations, providing not only capital but also engineering expertise, market access, and production infrastructure. With a goal to reduce or avoid 1 gigaton of CO2 emissions by 2050, Icos Capital takes a hands-on approach to investing, helping innovative startups scale quickly while ensuring measurable environmental impact. Some of its successful portfolio companies include Carbon Clean, eAgronom, and Holiferm, each making strides in carbon capture, regenerative agriculture, and sustainable product developmen. Icos Capital continues to manage multiple funds, the latest being Icos IV, with a targeted size of €100 million, designed to accelerate sustainability across industries. The firm primarily focuses on European companies but also supports those in the U.S. and Asia with strong ties to the European market.

Idinvest Partners, founded in 1997 and headquartered in Paris, France, is a leading European private equity and venture capital firm. The firm specializes in low and middle-market segments, investing across various stages, including early-stage, growth-stage, and later-stage companies. Idinvest Partners is particularly active in the IT, healthcare, and financial services sectors, and has made notable investments in companies such as Deezer, Criteo, Dailymotion, and Sigfox​. In 2018, Idinvest Partners was acquired by Eurazeo, creating a combined entity with over $15 billion in assets under management. This acquisition has bolstered Idinvest’s capacity to support innovative startups and expand its reach globally​. The firm has a diversified investment strategy, leveraging its expertise in venture and growth capital, private debt, and private equity to drive growth and value creation in its portfolio companies. Idinvest Partners operates with a strong presence in Europe and has extended its investments to the United States and Asia. Recent investments include companies like Dark (aerospace and defense) and Cove (real estate services), highlighting its broad investment approach across different sectors​.

IDC Ventures, founded in 2019 and headquartered in Copenhagen, is a venture capital firm that focuses on investing in early to growth-stage companies across fintech, marketplaces, and digital platforms. With a mission to support founders driving digital innovation, IDC Ventures backs companies that are creating generational shifts in industries such as financial services and technology. Their portfolio includes companies like Curve, GoTrendier, and NovoPayment, reflecting their focus on fintech and software solutions. The firm is known for its thesis-driven investment strategy, where it identifies key sectors experiencing behavioral shifts and concentrates its investments to scale these businesses. IDC Ventures typically leads investment rounds, taking an active role in governance and business development to ensure portfolio companies thrive. They also emphasize creating co-investment opportunities and building a valuable network of investors and entrepreneurs across Europe, the US, and Latin America. IDC Ventures’ collaborative approach, combined with its strong ties to over 100 family offices, positions it as a key player in helping startups achieve substantial growth.

IDIA Capital Investissement is a venture capital and private equity firm based in Montrouge, France. It operates as the investment arm of the Crédit Agricole Group, focusing on minority equity investments to support the growth and development of mid-sized companies (ETIs) and small to medium-sized enterprises (SMEs). Established over 30 years ago, IDIA specializes in sectors such as agribusiness, viticulture, healthcare, tourism, and energy transition​. The firm manages a substantial portfolio with assets under management totaling €2.2 billion. They typically invest between €1 million and €50 million per transaction, leveraging the extensive Crédit Agricole network to provide strategic and financial support to their portfolio companies. IDIA Capital Investissement is committed to responsible investing, emphasizing environmental, social, and governance (ESG) criteria in their decision-making process. This approach aligns with Crédit Agricole's broader mission of promoting sustainable finance and supporting projects that address key societal and environmental challenges​.

iGan Partners is a leading venture capital firm based in Toronto, Canada, specializing in early-stage investments in technology and healthcare sectors. Founded in 1999, iGan Partners has built a strong portfolio by partnering with innovative startups and helping them scale their disruptive technologies. The firm has a diverse portfolio that includes companies like Think Research, a provider of clinical content and technology solutions; MolecuLight, which develops imaging devices for wound care; and eSight, known for creating electronic glasses that improve vision for the legally blind. Other notable investments include MedChart, a platform that enables businesses to access and exchange patient-authorized digital health information, and Cosm Medical, which designs medical devices for personalized pelvic health solutions. iGan Partners typically invests in seed and Series A rounds, with a focus on companies in the healthcare sector, including medical devices, digital health, and health IT. They have been involved in funding rounds for companies like Hyivy Health and Curv Health, supporting innovative solutions in personal health and wellness. The firm is led by a team of experienced professionals, including Founder and Managing Partner Sam Ifergan and Chief Medical Officer Dr. Lorena Tora. Their extensive expertise in healthcare and technology enables them to provide valuable support and strategic guidance to their portfolio companies​.

iGlobe Partners, founded in 1999 and headquartered in Singapore, is a prominent venture capital firm with a global investment strategy. The firm focuses on early to growth-stage investments in tech-driven sectors such as smart cities, synthetic biology, and fintech. iGlobe Partners has a strong track record of investing in transformative companies and has managed funds exceeding USD 500 million​. Their diverse portfolio includes notable companies such as Matterport, which provides AI-powered 3D data platforms to create digital twins of physical spaces, and NerdWallet, a popular personal finance company. Additionally, they have invested in C2i Genomics, a leader in cloud-based cancer diagnostics, and Twist Bioscience, which is revolutionizing DNA synthesis. iGlobe Partners' investment approach emphasizes collaboration with top-tier scientific and entrepreneurial talent to drive innovation. The firm has been instrumental in scaling game-changing companies across the U.S., Europe, and Asia, leveraging its extensive global network to support portfolio companies in expanding their market reach​. With the recent close of their USD 100 million iGlobe Platinum Fund III, the firm continues to invest in high-growth areas, particularly focusing on innovations in healthcare, logistics, and smart city technologies. This strategic focus aims to capitalize on the accelerated adoption of technology driven by the COVID-19 pandemic, promising substantial returns in the long term.

Illumina Ventures is an influential venture capital firm focused on advancing genomics and precision health. Established in partnership with Illumina, the firm targets early-stage companies driving innovation in life science tools, therapeutics, diagnostics, and personal wellness. Their notable investments include leading companies like 23andMe, Twist Bioscience, and Sherlock Biosciences. Illumina Ventures primarily operates within North America but maintains a global investment scope. The firm typically leads investment rounds, with a strong emphasis on startups harnessing cutting-edge technologies like AI, machine learning, and synthetic biology to improve human health. Recent investments highlight their commitment to transformative technologies, with companies such as Actym Therapeutics and Redshift Bio joining their portfolio. Key figures at Illumina Ventures include founding partner Nick Naclerio, who brings extensive experience from his tenure at Illumina Inc., and Malek Faham, promoted to Chief Scientist. The team is complemented by experts like Thomas Ybert of DNA Script, underscoring the firm's robust support for its portfolio companies.

Illuminate Financial is a London-based venture capital firm specializing in fintech and enterprise software, with additional offices in New York and Singapore. Founded in 2014 by Mark Beeston, the firm focuses on early-stage companies that are transforming financial services through innovative technology. Illuminate operates with a thesis-driven approach, targeting businesses that address critical challenges in areas like capital markets infrastructure, data analytics, and regulatory compliance. The firm has raised significant capital across multiple funds, including a recent $235 million fund that attracted major financial institutions as investors, such as J.P. Morgan, Barclays, and Deutsche Börse. Illuminate’s unique value lies in its deep industry expertise, stemming from its team’s experience as operators, consumers, and entrepreneurs within the financial sector. This enables them to offer both capital and strategic guidance to portfolio companies, helping them navigate complex market environments and scale successfully. Their portfolio includes companies like Net Purpose and other fintech pioneers that focus on providing cutting-edge solutions for financial markets and impact-driven investments.

Imec.xpand is a venture capital firm based in Leuven, Belgium, founded in 2017. The firm focuses on early-stage investments in deep-tech innovations, particularly those based on nanoelectronics. Their investment areas span health, agtech, and semiconductor technology, aiming to foster significant technological advancements and growth. Notable investments include PsiQuantum, a quantum computing company, and Axelera AI, a startup developing AI applications for edge computing. Other prominent portfolio companies are Spectricity, which specializes in hyperspectral sensing solutions, and Optalysys, an AI-driven big data and machine learning company. Imec.xpand typically leads funding rounds, with investment amounts averaging around $21 million per round. The firm has made 41 investments to date, with a robust global presence, investing in companies from the U.S., Europe, and beyond. Their strategic approach leverages their affiliation with Imec, a world-renowned R&D hub for nanoelectronics and digital technologies, providing startups with unparalleled access to cutting-edge research, expertise, and infrastructure​. Key team members include Tom Vanhoutte and Frank Bulens, who bring extensive experience in deep tech and venture capital, further solidifying Imec.xpand’s position as a leader in the tech investment space​.

Impact Venture is a London-based family office with a strong focus on early-stage investments that drive positive social and environmental impact. Their portfolio includes groundbreaking companies like Mango Materials, which produces biodegradable plastics, and Cadence Health, a U.S.-based firm revolutionizing access to over-the-counter birth control. Impact Venture backs startups in sectors like health, sustainability, and tech-driven solutions, including vertical farming and synthetic biology. Geographically, they prioritize investments in regions where these technologies can address large-scale global challenges. Their approach combines patient capital with a hands-on partnership, emphasizing long-term relationships and follow-on funding to help ventures scale successfully. Impact Venture typically provides early-stage funding between £100,000 and £500,000 and invests in bold leaders using advanced technologies to solve urgent societal issues. The firm’s strategy is underpinned by a strong belief in measurable outcomes—both financial and impact-driven—and they prefer startups with strong scientific or technological foundations. The CEO, Kateryna Filippi, leads the team from London, bringing deep expertise in supporting ventures that are reshaping industries​.

Imprimatur Capital is a venture capital firm with a strong focus on early-stage technology startups in the Baltic Sea region. Established in 2003, the firm has carved out a niche in sectors like B2B software, digital health, robotics, and automation. With a global perspective, Imprimatur helps startups with scalable business models reach international markets. The firm typically invests between €200k and €2 million in companies that have demonstrated initial revenue, particularly those with a minimum of €5,000 MRR. Imprimatur’s team operates from offices in Riga, London, and Singapore, bringing deep expertise in engineering, life sciences, entrepreneurship, and finance to the table. This diverse skill set enables the firm to provide more than just capital; they offer strategic guidance to ensure startups achieve sustainable growth. Imprimatur’s investment strategy is built on identifying ambitious founders with innovative solutions that address significant market needs. Their portfolio includes over 70 startups, such as Anatomy Next, which has successfully scaled with their support. Although their current fund is fully invested, Imprimatur continues to maintain a strong presence in the venture capital ecosystem, focusing on driving technological advancements that have the potential to impact industries globally. Their commitment to fostering innovation is evident in their active involvement in the startups they back, providing long-term support that goes beyond initial funding to include mentorship, market access, and business development expertise.

Impro Ventures is a venture capital firm that focuses on early-stage tech startups, providing funding, resources, and mentorship to help entrepreneurs turn their visions into reality. The firm operates globally with offices in Barcelona, Miami, Berlin, Vilnius, and Eau Claire, and supports startups in diverse sectors including analytics, AI, biotech, fintech, clean tech, and more​. Founded by a team with extensive experience in talent development, venture investments, and startup operations, Impro Ventures targets pre-seed and seed stage investments. They are particularly interested in startups in emerging markets such as Africa, Latin America, and Southeast Asia, emphasizing a hands-on, inclusive approach to investment.

In-Q-Tel (IQT) is a non-profit, strategic venture capital firm established in 1999 by the CIA to bridge the gap between the technological innovations of the private sector and the needs of U.S. intelligence and defense agencies. With a global investment platform, IQT identifies and invests in startups across frontier technologies like AI, cybersecurity, biotech, space systems, and microelectronics. Their investments are designed to enhance national security, working closely with partners such as the CIA, NSA, U.S. Space Force, and international allies like the U.K. and Australia. IQT typically invests between $250,000 and $3 million, leveraging both equity investments and development agreements. They focus on startups that offer dual-use technologies—solutions that serve both commercial and government applications. Over its 25-year history, IQT has backed over 500 companies, many of which have grown into industry leaders, including Palantir, GitLab, and Xanadu. The firm’s investments have led to over 30 unicorns and numerous public company exits, illustrating its significant impact on both commercial and national security landscapes.

INCO Ventures, part of the INCO Group, is a venture capital firm based in Paris, France, specializing in impact investing. Founded in 2011, INCO Ventures focuses on backing startups that drive social and environmental change. The firm manages over €500 million across various funds, including direct management of €110 million and advisory roles for additional funds totaling €450 million. INCO Ventures invests in companies that are shaping a more inclusive and sustainable economy. Their portfolio includes more than 100 impact companies across diverse sectors, such as energy, ecological transitions, digital economy, education, and healthcare​​. They ensure a triple return on investment—economic, social, and environmental—measured using their unique impact assessment tool, INCO Ratings. The broader INCO Group is dedicated to advancing economic opportunities and supporting impact entrepreneurs through initiatives like INCO Academy, INCO Entrepreneurs, and INCO Spaces, which provide skilling programs, support for underrepresented founders, and co-working spaces respectively​.

Indaco Venture Partners SGR, established in 2016, is Italy's largest independent venture capital firm, managing over €350 million across six funds. Their investment strategy is centered on breakthrough innovations, focusing primarily on sectors like electronics, robotics, medtech, biotech, pharma, and digital technologies. Indaco is renowned for supporting startups with cutting-edge proprietary technologies, typically participating in seed to Series B rounds with investments starting from €3 million. The firm's geographic reach spans Europe, the U.S., and Israel, but its core focus remains on Italian enterprises. Their anchor investors include leading institutions like Intesa Sanpaolo, Fondazione Cariplo, and the European Investment Fund, underscoring their credibility in the European VC landscape. Indaco has also forged strategic partnerships in digital and biotech sectors, such as with growITup and Università di Milano, allowing them to leverage deep industry expertise. Led by co-founders Davide Turco, Elizabeth Robinson, and Antonella Beltrame, the team has a wealth of experience in venture capital and has achieved numerous successful exits, including IPOs and major corporate transactions. Indaco's diverse team brings backgrounds from private equity, science, and technology research, giving them a unique ability to identify high-potential startups. For founders, Indaco’s rigorous selection process favors companies that can demonstrate technological leadership and scalability, especially those looking to expand globally. Their track record of over 40 portfolio companies and more than 15 successful exits makes them a key player in fostering the next generation of innovative leaders.

Index Ventures is a renowned venture capital firm with dual headquarters in San Francisco and London. Founded in 1996, the firm has a strong track record of investing in transformative companies across various sectors including technology, fintech, healthcare, and consumer products. Notable investments by Index Ventures include some of the biggest names in tech and business today. These include Dropbox, Figma, Slack, Roblox, Adyen, and Deliveroo. The firm has been instrumental in the growth of these companies, providing both financial backing and strategic support​. Index Ventures has raised several significant funds to support its investment strategy. Recently, they closed $3.1 billion in new funds, which are spread across early-stage, growth-stage, and seed-stage investments. This substantial capital allows them to back innovative startups from inception through to maturity​. The firm is known for its deep commitment to the entrepreneurs they support, emphasizing close partnerships and long-term growth. This approach has made Index Ventures a preferred partner for visionary founders looking to scale their businesses globally​.

Indico Capital Partners, based in Lisbon, Portugal, focuses on early-stage technology and sustainability investments, especially in AI, SaaS, fintech, and the blue economy. Notable investments include Rows, FRVR, and Oceano Fresco. With over €194 million in assets under management across six funds, Indico plays an active role in scaling startups from Portugal and Spain to a global level. Indico typically leads rounds at the seed stage, investing between €100K to €5M per company, and often co-invests with larger firms like Accel. They also offer hands-on support through their Indico Founders Program, providing mentorship and access to their international network. Indico is particularly focused on companies with global ambitions, leveraging their team’s expertise and investor network to help scale ventures beyond local markets. The team includes co-founders Stephan Morais, Ricardo Torgal, and Cristina Fonseca, all of whom have strong backgrounds in tech and venture capital. They favor founders who demonstrate resilience and ambition, and startups are encouraged to approach them with a clear focus on scalability. Indico’s strategic focus is on sustainable, high-impact innovations, with a particular interest in companies contributing to marine ecosystem health and climate tech.

Industrifonden, established in 1979 by the Swedish government, is a leading venture capital firm based in Stockholm. With over SEK 5 billion in assets under management, the firm focuses on early-stage investments, typically from seed to A-round funding. Their initial investments range from SEK 10 to 50 million, with the capacity to invest significantly more throughout the lifecycle of their portfolio companies. Industrifonden's investment strategy centers on three main areas: Deep Tech, Life Sciences, and Transformative Technologies. They support innovative startups that address significant societal challenges and have the potential to revolutionize their industries. The firm's evergreen fund structure allows for a long-term focus, fostering sustainable growth and development. Notable portfolio companies include Telness, AnaCardio, Cascade Drives, Asgard Therapeutics, and TrusTrace, reflecting the diversity and impact of their investments. Industrifonden's commitment to long-term value creation and supporting breakthrough innovations makes them a crucial player in the Nordic venture capital landscape.

ING is a global financial institution with a strong focus on sustainable investment, exemplified by initiatives like the world's first sustainability improvement fund. This fund encourages companies to enhance their ESG performance by linking financing terms to sustainability goals. ING collaborates with venture capitalists such as SmartFin, specializing in financial technologies, to support innovation in the fintech sector. The firm has actively divested non-core assets, such as the sale of ING Life Korea to MBK Partners, to streamline its operations and focus on core banking activities. This strategic shift supports ING's broader goal of fostering sustainable development across its investment portfolio. ING's private equity engagements reflect its commitment to environmental and social governance, supporting businesses that align with their sustainability ethos. This approach not only helps ING achieve attractive returns but also contributes positively to global sustainability efforts.

Inkef Capital, founded in 2010 and based in Amsterdam, is a prominent early-stage venture capital firm focused on technology and healthcare sectors. They prioritize investments in therapeutics, digital health, medical devices, and areas like the Future of Commerce, Future of Work, Data & AI Stack, Fintech, and DeepTech. Inkef is known for their patient, long-term approach, supporting companies from seed to Series A rounds and beyond. Inkef’s portfolio includes notable investments in companies such as GitLab, Onward Medical, and Aidence, reflecting their commitment to impactful, innovative solutions. They have a track record of successful exits, further emphasizing their strategic investment prowess. The firm’s investment strategy revolves around identifying mission-driven entrepreneurs addressing significant global challenges with unique solutions. Inkef prefers companies with ambitious teams ready to scale globally. They value deep, hands-on collaboration, aiming to build lasting companies rather than quick exits​. Key team members include Managing Partner Reitze Douma, Senior Partner Frank Lansink, and Partners like Thijs Cohen Tervaert and Simone Botti. Their diverse and experienced team is dedicated to fostering innovation and supporting founders through various stages of growth. For startups looking to engage with Inkef Capital, demonstrating a clear, innovative vision and readiness for global scale are crucial. They are approachable through their structured process and value long-term strategic partnerships aimed at creating substantial, sustainable impact​.

InMotion Ventures is the venture capital arm of Jaguar Land Rover (JLR), focusing on early-stage investments that align with JLR's strategic goals. Established as a key component of JLR’s Open Innovation programme, InMotion Ventures supports startups from Pre-seed to Series A stages in sectors such as climate tech, industrial technology, and enterprise solutions. Their investments aim to accelerate JLR's Reimagine strategy, which focuses on sustainability and innovation in luxury vehicles and services. The fund offers startups not just capital, but also access to a rich ecosystem of innovators and the broader resources of JLR and Tata Group. This includes partnership opportunities, domain expertise, and significant exposure, helping startups gain a competitive edge and achieve growth. InMotion Ventures' portfolio includes companies like Ascend Elements, which focuses on lithium-ion battery recycling, and ev.energy, which connects electric vehicles to grid networks for greener and more efficient charging. Their investment strategy emphasizes supporting technologies that contribute to a sustainable future.

EIT InnoEnergy is a leading venture capital firm based in Europe, focusing on sustainable energy and cleantech investments. Founded in 2010, the firm has supported over 480 startups and manages an equity portfolio of more than 200 companies, aiming to generate significant revenue and reduce global carbon footprints by 2030. The firm’s portfolio includes innovative companies across various sectors such as energy storage, renewable energies, green hydrogen, and sustainable cities. Notable investments include Prime Battery Technologies, which provides affordable energy storage solutions, and Novatron, which develops nuclear fusion reactors for large-scale energy production. Other significant investments are Nevomo, which works on magnetic levitation-based transportation systems, and GravitHy, which aims to decarbonize steel production using hydrogen. EIT InnoEnergy has been recognized as Europe’s top impact investor in cleantech, reflecting its commitment to driving the energy transition and supporting innovations that combat climate change. The firm collaborates with a wide network of strategic partners, including global corporations and financial institutions, to provide comprehensive support to its portfolio companies. This ecosystem approach helps startups overcome challenges and achieve market success, ensuring they can scale effectively and contribute to global sustainability goals.

Innogest Capital, founded in 2005 and based in Turin, Italy, is a prominent venture capital firm with additional offices in Milan, Geneva, and San Francisco. The firm focuses primarily on early-stage investments, particularly in the healthcare and digital sectors. Notable investments include companies like Empatica, Affera, and BetaGlue Technologies. Innogest Capital has a diversified portfolio across several industries. In healthcare, they have invested in companies such as GreenBone, MedLumics, and Newronika, focusing on innovative medical devices, diagnostics, and therapeutic platforms. Their technology investments include digital platforms like MioAssicuratore, Soul-K, and Beintoo, which span online insurance brokerage, food delivery services, and digital marketing solutions. The firm's strategy involves investing between €0.2 million to €2 million in promising startups, helping them scale through hands-on support and leveraging their extensive network. They have made 85 investments to date and have successfully exited from companies like Affera, Everli, and Renovacor. Key team members include Claudio Giuliano, the Co-Founder and CEO, and partners like Giovanni Leo and Franco Rutili, who bring a wealth of experience in venture capital and industry-specific expertise. Innogest Capital is known for its robust support of entrepreneurial visionaries and its commitment to fostering innovation across various sectors, making it a key player in the European venture capital landscape.

Innovation Capital is a €21.1 million venture capital fund based in Sofia, Bulgaria, focused on supporting early-stage startups. The fund primarily invests in pre-seed and seed stages, offering equity and quasi-equity funding to companies across a variety of sectors. Their investment approach is sector-agnostic, covering industries like AI, e-commerce, healthcare, education, fintech, and cybersecurity. Innovation Capital aims to foster high-potential startups that can introduce disruptive innovations and scalable solutions within the local and international markets. The firm has built a diverse portfolio, with more than 100 companies under its belt, including innovative projects like Ubitrack Sport (machine learning for sports analytics) and Kabinet (telemedicine for mental health). They actively seek projects with strong business models and potential for growth, providing investments that range from €25,000 to €1 million depending on the stage of the startup. Innovation Capital also plays a key role in the regional ecosystem by managing accelerator programs, such as XLRadar, which helps early-stage startups refine their business models and gain market traction. The fund receives support from European Structural and Investment Funds, aiming to stimulate competitiveness and economic growth within Bulgaria​.

Innovation Industries is a leading European venture capital firm focused on deep tech investments. With approximately €850 million in assets under management, they specialize in sectors such as industrial tech, med tech, and food & agri tech. The firm targets high-growth potential companies that offer sustainable solutions and have a significant societal impact. Innovation Industries supports companies throughout their growth journey, from early-stage funding to scaling up. They can invest up to €50 million per company over multiple funding rounds, ensuring robust financial backing and strategic guidance. Their portfolio includes cutting-edge companies like Nearfield Instruments, Axelera AI, and Pharrowtech. The team at Innovation Industries brings diverse expertise in fields like physics, engineering, and biotechnology, providing a strong foundation to identify and nurture groundbreaking technologies. Their commitment to sustainability and responsible investment is evident in their rigorous environmental, social, and governance (ESG) criteria. Overall, Innovation Industries is dedicated to driving technological advancements that address fundamental challenges, aiming to create long-term value for both their investors and society at large.

Innovation Works (IW) is a leading early-stage investor in southwestern Pennsylvania, primarily focused on technology startups. Founded as part of the Ben Franklin Technology Partners network, IW has significantly contributed to the region's economic growth by investing in over 700 companies, which have collectively raised $3.3 billion in follow-on funding and created over 20,000 jobs. Notable sectors in IW's portfolio include robotics, life sciences, software, and clean energy. Some of their prominent investments are in companies like Aurora Innovation and Stack AV, which are part of the thriving robotics and autonomous vehicle industries in Pittsburgh. IW's support extends beyond funding, providing mentorship and resources through their accelerators, AlphaLab and AlphaLab Gear. In 2023, despite a national downturn in venture capital, Pittsburgh's tech sector saw a substantial increase in investments, reaching $3.12 billion, driven by significant activity in automation and AI. This positions Pittsburgh as an emerging tech hub with a growing number of new investors and global technology companies setting up satellite offices in the region. For startups looking to connect with IW, demonstrating innovation and potential for significant impact in high-opportunity markets will align with IW’s investment philosophy.

InnovationQuarter is the economic development agency for the Province of Zuid-Holland, focusing on enhancing the region’s economic structure through innovation. The agency is committed to supporting startups and scale-ups, particularly in sectors like high-tech systems, life sciences, energy, and the circular economy. InnovationQuarter offers various investment funds. InnovationQuarter Capital provides up to €5 million for innovative startups and scale-ups with high technological risk, supporting companies with strong management teams and scalable business models. ENERGIIQ, a €35 million fund, is aimed at commercializing proven energy innovations to reduce CO2 emissions, offering up to €4.3 million in venture capital and emphasizing collaborations with reputable co-investors. UNIIQ, a €47 million seed fund, focuses on the proof-of-concept phase, providing up to €350,000 in risk capital for the technical and market validation of innovations. Additionally, InnovationQuarter plays a significant role in internationalization, assisting Dutch businesses in expanding abroad and supporting foreign companies in establishing a presence in Zuid-Holland. The agency collaborates with various stakeholders, including major corporations, SMEs, educational institutions, and government organizations, to foster a dynamic and innovative ecosystem.

Innovestor Group is a prominent Nordic venture capital firm headquartered in Helsinki, Finland. Founded in 2014, it is one of the most active early-stage investors in the region, managing over €250 million across multiple funds. Innovestor focuses on sectors like life sciences, industrial technology, and digital health, with a particular emphasis on sustainable and scalable innovations. The firm is known for being the "first VC check" for many startups, supporting them from pre-seed through to Series A, primarily across the Nordics and Baltics. The firm operates through a combination of direct investments and co-investment syndication, making it a versatile player in the venture capital ecosystem. Innovestor’s portfolio includes nearly 100 high-growth companies, reflecting a diversified approach across sectors such as biotech, clean energy, and industrial automation. Recent initiatives include a €30 million Industry 4.0 fund aimed at fostering industrial tech advancements, and a dedicated €90 million Life Science & Health fund to support breakthroughs in biotech and healthcare. Innovestor distinguishes itself by not only providing capital but also facilitating collaborations between startups and large corporations, as seen through its accelerator programs like the PALO Accelerator. This approach helps startups scale efficiently by tapping into strategic partnerships and industry expertise. With offices throughout the region, Innovestor continues to drive the growth of Nordic+ startups by enabling them to scale internationally.

Inovo VC is a seed-stage venture capital firm based in Warsaw, Poland, with a focus on startups from Central and Eastern Europe (CEE). They typically invest between €0.5 million and €4 million in early-stage companies, with the potential for follow-on investments up to €10 million. Inovo's portfolio includes over 30 companies, with notable successes such as Booksy, Infermedica, and Packhelp, each surpassing €100 million in valuation. Inovo's investment strategy spans various industries, including healthcare, AI and machine learning, developer tools, and SaaS-enabled marketplaces. The firm aims to support startups that can achieve significant global market presence and reach $100 million in revenue within a few years. They have a strong track record of working alongside other prominent funds such as a16z, Google’s Gradient Ventures, and Insight Partners. The fund's leadership team, consisting of Tomasz Swieboda, Michał Rokosz, and Maciej Małysz, brings extensive experience and a proven ability to identify and nurture high-potential startups. Their recent third fund, closed at €105 million, continues to support ambitious founders in the CEE region, aiming to create at least ten new unicorns in the coming years. Inovo VC's backers include private investors like European family offices and Polish tech entrepreneurs, as well as institutional investors such as the European Investment Fund and IFC, a member of the World Bank Group.

Insight Partners, founded in 1995 and headquartered in New York City, is a global venture capital and private equity firm renowned for investing in high-growth technology, software, and internet companies. The firm has a vast portfolio of over 1,600 investments, including notable companies like Calm, monday.com, WalkMe, and Checkout.com​. The firm is particularly known for its significant investments across various sectors such as IT infrastructure, cybersecurity, fintech, e-commerce, and DevOps. In 2022, Insight Partners closed its largest fund to date, raising over $20 billion, which underscored its aggressive investment strategy and commitment to high-growth companies​​. Insight Partners employs a hands-on approach to supporting its portfolio companies, offering extensive resources through its Onsite team. This team comprises over 130 experts in areas like sales, marketing, product development, and talent acquisition, dedicated to helping companies scale efficiently. This support has been crucial in helping many of their portfolio companies achieve significant growth and successful exits​. Overall, Insight Partners' combination of substantial financial resources, strategic support, and industry expertise positions it as a leading player in the global venture capital landscape​.

Insta Ventures is a venture capital firm founded in 2019, focusing on early-stage investments in IT and technology sectors. Based in Limassol, Cyprus, the firm targets startups in the seed to pre-Series A stages, typically investing between $100,000 and $500,000. Insta Ventures is known for its swift decision-making process, often concluding investment deals within one to two months after the first meeting. The firm’s investment strategy is centered around fast-growing, disruptive tech companies, particularly those in SaaS, B2B/B2B2C, AI, AR/VR, and FinTech. Insta Ventures places a strong emphasis on companies with a global market scope and those generating $0.1 to $1 million in annual recurring revenue. While the firm invests globally, it has a special focus on startups from the Nordics and Baltics. Insta Ventures also values co-investments and partners with other venture funds and accelerators to support its portfolio companies. The firm's portfolio includes companies like Ex-human, an AI platform for immersive conversations, and Warren.io, a cloud management platform.

Interstellar Ventures is a Berlin-based venture capital fund with a focus on early-stage investments, primarily in the fields of SaaS, content marketing, and blockchain technologies. The firm often targets startups in the European market, particularly Germany, while also exploring global opportunities in emerging tech sectors. Despite its small portfolio, Interstellar Ventures tends to invest around $3 million per deal, preferring to support seed-stage companies with early revenue models. Their investment strategy emphasizes backing innovative startups in the digital economy, particularly those working on cutting-edge solutions within the crypto and decentralized ecosystems. Although they have not led any funding rounds yet, their presence in the blockchain sector has grown, with a handful of investments in token-based projects. The firm has shown particular interest in social media and marketing tech that leverage blockchain. While Interstellar Ventures is not one of the most active funds, it has steadily built a pipeline for future growth through co-investments with other leading VCs in the space. For startups looking to connect, building a strong business case around decentralized solutions or content-driven technologies is key to attracting their interest.

InterWest Partners, established in 1979, is a venture capital firm focused on early-stage investments in the information technology and healthcare sectors. Based in Menlo Park, California, the firm has raised over $2.8 billion across ten funds. Throughout its history, InterWest has backed more than 250 companies, achieving 97 IPOs and participating in 95 acquisitions. InterWest Partners IX, one of their notable funds, closed at $606 million and primarily invests in early-stage companies within its targeted sectors. The firm is known for its successful investments in companies such as Doximity, Canva, Braze, and Glaukos. InterWest's approach focuses on partnering with world-class entrepreneurs to build leading companies in IT and healthcare, supporting them through various growth stages. While InterWest Partners is not currently seeking new investments, their legacy includes influential early wins in companies like Xilinx and CIENA in the IT sector, and COR Therapeutics and Ventritex in healthcare, cementing their reputation as a key player in the venture capital landscape.

Inven Capital, founded in 2014, is a Czech-based venture capital firm primarily backed by the major European energy utility ČEZ and the European Investment Bank (EIB). The firm focuses on climate tech and energy-related startups, particularly those innovating in areas such as renewable energy, energy efficiency, smart grids, mobility solutions, and energy storage. With over €500 million in funds under management, Inven Capital supports companies from early to growth stages across Europe and Israel. The firm seeks to invest in companies with proven business models that are at the growth stage, aiming to drive significant advancements in decarbonization and sustainability. Its portfolio includes successful ventures like German energy storage company sonnen, Israeli electromobility platform Driivz, and smart thermostat leader tado°. Beyond providing capital, Inven Capital offers strategic guidance, leveraging its strong connections within the energy sector to help startups scale their technologies and enter new markets. Led by Managing Director Petr Mikovec, Inven Capital emphasizes long-term value creation, sustainability, and supporting the transition to a cleaner energy future.

Inventages Venture Capital, founded in 2000 by Gunnar Weikert, is the venture capital arm of Nestlé, headquartered in Nassau, Bahamas. The firm specializes in health care, life sciences, pharmaceuticals, cosmeceuticals, enabling technologies, and medical devices. Inventages has a broad investment focus, participating in seed, early, mid, and late-stage ventures. Notable investments include Accera, a biotechnology firm focused on therapies for neurodegenerative diseases, and Phagenesis, which develops treatments for dysphagia. Other significant investments are Shield Therapeutics, known for its iron deficiency treatments, and Cognoptix, which is developing diagnostics for Alzheimer's disease​. Inventages typically invests with an average round size of $14 million, demonstrating a strong commitment to substantial funding rounds. The firm is actively involved in guiding its portfolio companies through strategic growth and development stages. Key team members include Gunnar Weikert (Founder and CEO), Thomas Bayerl, and Wolfgang Reichenberger, all bringing significant expertise in venture capital and life sciences to the table. Inventages is particularly noted for its rigorous due diligence process and a strong focus on the commercial viability of scientific innovations. This approach has enabled them to support groundbreaking developments in health and wellness sectors​.